Brown Capital Management’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,508
Closed -$254K 90
2025
Q1
$254K Sell
3,508
-3,993
-53% -$289K 0.01% 94
2024
Q4
$555K Sell
7,501
-9,009
-55% -$667K 0.01% 89
2024
Q3
$1.09M Sell
16,510
-18,661
-53% -$1.23M 0.02% 79
2024
Q2
$3.25M Sell
35,171
-125
-0.4% -$11.5K 0.07% 69
2024
Q1
$3.37M Sell
35,296
-243
-0.7% -$23.2K 0.06% 73
2023
Q4
$2.71M Sell
35,539
-2,497
-7% -$190K 0.04% 73
2023
Q3
$2.64M Sell
38,036
-650
-2% -$45K 0.04% 71
2023
Q2
$3.65M Sell
38,686
-4,468
-10% -$421K 0.05% 66
2023
Q1
$3.57M Buy
43,154
+827
+2% +$68.4K 0.05% 55
2022
Q4
$3.16M Sell
42,327
-2,578
-6% -$192K 0.05% 59
2022
Q3
$3.71M Sell
44,905
-82
-0.2% -$6.78K 0.05% 51
2022
Q2
$4.28M Hold
44,987
0.06% 50
2022
Q1
$5.3M Buy
44,987
+644
+1% +$75.8K 0.05% 50
2021
Q4
$5.75M Buy
44,343
+235
+0.5% +$30.4K 0.05% 52
2021
Q3
$4.99M Buy
44,108
+1,479
+3% +$167K 0.04% 55
2021
Q2
$4.42M Buy
42,629
+748
+2% +$77.5K 0.03% 52
2021
Q1
$3.5M Buy
41,881
+7,098
+20% +$594K 0.03% 59
2020
Q4
$3.17M Buy
34,783
+2,154
+7% +$196K 0.02% 62
2020
Q3
$2.6M Buy
32,629
+64
+0.2% +$5.11K 0.02% 61
2020
Q2
$2.25M Buy
32,565
+2,784
+9% +$192K 0.02% 64
2020
Q1
$1.87M Sell
29,781
-75
-0.3% -$4.71K 0.02% 58
2019
Q4
$2.32M Sell
29,856
-336
-1% -$26.1K 0.02% 60
2019
Q3
$2.21M Buy
30,192
+1,242
+4% +$91K 0.02% 61
2019
Q2
$1.78M Sell
28,950
-369
-1% -$22.7K 0.02% 63
2019
Q1
$1.87M Buy
29,319
+1,563
+6% +$99.7K 0.02% 64
2018
Q4
$1.42M Buy
27,756
+174
+0.6% +$8.88K 0.02% 68
2018
Q3
$1.6M Buy
27,582
+1,308
+5% +$75.9K 0.01% 70
2018
Q2
$1.28M Buy
26,274
+3,099
+13% +$150K 0.01% 71
2018
Q1
$1.08M Buy
23,175
+5,373
+30% +$250K 0.01% 77
2017
Q4
$669K Buy
17,802
+4,467
+33% +$168K 0.01% 98
2017
Q3
$486K Buy
+13,335
New +$486K 0.01% 114